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3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (statins) are cholesterol-lowering drugs that exert other cellular effects
and underlie their beneﬁcial health effects, including those associated with myocardial remodeling. We recently demonstrated
that statins induces apoptosis and autophagy in human lung mesenchymal cells. Here, we extend our knowledge showing that
statins simultaneously induces activation of the apoptosis, autophagy and the unfolded protein response (UPR) in primary
human atrial ﬁbroblasts (hATF). Thus we tested the degree to which coordination exists between signaling from mitochondria,
endoplasmic reticulum and lysosomes during response to simvastatin exposure. Pharmacologic blockade of the activation of
ER-dependent cysteine-dependent aspartate-directed protease (caspase)-4 and lysosomal cathepsin-B and -L signiﬁcantly
decreased simvastatin-induced cell death. Simvastatin altered total abundance and the mitochondrial fraction of proapoptotic
and antiapoptotic proteins, while c-Jun N-terminal kinase/stress-activated protein kinase mediated effects on B-cell lymphoma 2
expression. Chemical inhibition of autophagy ﬂux with baﬁlomycin-A1 augmented simvastatin-induced caspase activation, UPR
and cell death. In mouse embryonic ﬁbroblasts that are deﬁcient in autophagy protein 5 and refractory to autophagy induction,
caspase-7 and UPR were hyper-induced upon treatment with simvastatin. These data demonstrate that mevalonate cascade
inhibition-induced death of hATF manifests from a complex mechanism involving co-regulation of apoptosis, autophagy
and UPR. Furthermore, autophagy has a crucial role in determining the extent of ER stress, UPR and permissiveness of hATF to
cell death induced by statins.
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Structural remodeling of the heart tissue, including ﬁbrosis,
cardiomyocyte death, hypertrophy of surviving myocytes and
proliferation of cardiac ﬁbroblasts, is a feature of cardiac
disease,heartfailureandatrialﬁbrillation.
1Cardiacﬁbroblasts
account for about two-thirds of the cells in the normal heart,
and maintain cardiac integrity during physiologic proliferation
and extracellular matrix turnover, and during cardiac
remodeling. They exhibit phenotype plasticity and have the
capacity for phenoconversion from a quiescent state (healthy
heart) to a proliferative myoﬁbroblast phenotype, acquiring
specialized contractile features in the diseased heart.
2,3 This
characteristic is the basis of tissue remodeling during normal
and pathologic wound healing associated with myocardial
infarction, heart failure and atrial ﬁbrillation.
Although statins are widely used in cardiovascular disease
prevention to lower cholesterol, they have other effects
unrelated to lipid reduction that are essential for their positive
impact on human health.
4,5 A number of studies show that
statin use is protective against maladaptive tissue remodeling
and of beneﬁt against heart failure.
6,7 Statins inhibit
3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase,
the proximal rate-determining enzyme in the multi-step
mevalonate cascade for cholesterol synthesis. Mevalonate
is used for cholesterol biosynthesis via squalene, but is
also a precursor for isoprenoids (farnesyl pyrophosphate
(FPP) and geranylgeranyl pyrophosphate (GGPP)). FPP and
GGPP are substrates for farnesylation of H-Ras and
geranylgeranylation of RhoA, post-translational modiﬁcations
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GTPases.
8,9
Mevalonate depletion can induce apoptosis, autophagy
and endoplasmic reticulum (ER) stress in cancerous
10 and
noncancerous cells.
11,12 In lung mesenchymal cells mevalo-
nate cascade inhibition activates apoptosis by a process
involving p53, disruption of mitochondrial ﬁssion and release
of proteins that interfere with inhibitor of apoptosis proteins
(IAP).
13 Simvastatin and a geranylgeranyl transferase I
inhibitor induce autophagy and apoptosis, but the response
is balanced by the p53 regulatory network.
12,14
Despite the role of ﬁbroblasts in cardiac pathologies, direct
effects of mevalonate cascade inhibition on human atrial
cardiac ﬁbroblast function have not been well studied.
Therefore, here we investigated cell death mechanisms
linked to mevalonate cascade inhibition in human atrial
ﬁbroblasts (hATF), focusing on apoptosis, autophagy and
ER stress. This study dissects the concomitant interplay
between these cellular events and their impact on human
atrial ﬁbroblast fate in response to its clinically relevant
stimulus, simvastatin. Our results could inﬂuence direction for
therapy related to cardiac ﬁbrosis.
Results
Mevalonate cascade inhibition induces cholesterol-
independent cell death. We ﬁrst identiﬁed concentration-
(0–20mM) and time-dependent (0–96h) effects of simvastatin
exposure on primary hATF cells. 3-(4,5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide (MTT) assay (Figure 1a)
revealed that all concentrations of simvastatin up to 20mM
signiﬁcantly induced cell death in primary hATF cells after 48
and 96h (Po0.001). Further experiments showed that though
exogenous mevalonate (2.5 and 5mM) signiﬁcantly blunted
both simvastatin-induced cell death (Po0.001) (Figure 1b) and
morphological changes in hATF cells (Figure 1c), co-treatment
with cholesterol was not sufﬁcient to prevent simvastatin-
induced cell death (P40.5) (Figure 1d). Thus, the simvastatin-
triggered toxicity relied upon mevalonate depletion, but
not on suppression of cholesterol synthesis per se.A ss e v e r a l
reports indicate that inhibiting the mevalonate cascade is
associated with reduced membrane anchoring of small
GTPase signaling proteins to contribute to statin-provoked cell
death,
13,15 we next assessed the impact of simvastatin
treatment on membrane localization of RhoA, RhoC and
Rac1/2/3. Simvastatin effectively reduced the abundance of
these proteins in plasma membrane fraction while increasing
cytosolic content (Figure 1e).
Mevalonate cascade inhibition activates the intrinsic
apoptotic pathway. SC scattergrams were collected after
treating hATF with simvastatin (10mM, 48 and 96h)
(Figure 2a). The induction of chromatic condensation without
loss of total nuclear DNA, features of apoptosis, was evident
from marked increase in the maximum pixel ﬂuorescence of
cells labeled with H33342 DNA dye. This was conﬁrmed by
examining ‘gallery photos’ of individual nuclear events from
relevant scattergram quadrants (Figure 2b). Quantitative
analysis of laser scanning cytometer (LSC) scattergrams
demonstrated that simvastatin treatment (10mM, 48 and
96h) signiﬁcantly activated apoptosis in primary hATF
(Figure 2c).
To investigate the effects of mevalonate cascade inhibition
on both extrinsic and intrinsic apoptosis pathways, we
measured cysteine-dependent aspartate-directed proteases
(caspase) cleavage in hATF following simvastatin treatment
for up to 120h (Figure 2d). Caspase-9 cleavage, a marker
of activation of the intrinsic apoptosis pathway was evident
within 24h and increased steadily thereafter. Cleavage of
caspase-3, -6 and -7 was also induced by statin exposure
after 48h, indicating that apoptosis was ongoing after the
initialcaspase-9induction.Wealsoexaminedactivationofthe
extrinsic apoptosis pathway by assessing Bid and found no
evidence for its cleavage to t-Bid (Figure 2d) or for cleavage
of caspase-8 (data not shown). Collectively these data show
that intrinsic apoptosis activation occurs selectively upon
mevalonate cascade inhibition.
Mevalonate cascade inhibition increases autophagy and
activates lysosomes. Statins can induce autophagy in
different cell models.
12,16 Here, we show that simvastatin
induces autophagy in hATF. First, analysis of ultrastructure
after statin exposure showed an increase in autophagosome
number (Figure 3a). Second, multiple protein markers
of autophagy were induced by simvastatin treatment:
these included microtubule-associated protein light chain
3b (LC3b) lipidation,
17 ubiquitination-dependent Atg5-12
formation
18 and beclin-1 expression
19 (Figure 3b). Third,
we investigated lysosomal activation (increase in lysotracker
red staining) and formation of LC3 punctae and found that
simvastatin exposure markedly induced these responses
(Figures 3c and d). We also found that simvastatin induced
pronounced cathepsin-B and -L cleavage (Figure 3e).
Furthermore, we observed that speciﬁc inhibitors of cathe-
psin-B (CA-074-OME) and cathepsin-B/L (z-FF-FMK) sig-
niﬁcantly decreased simvastatin-induced cell death in hATF
(Po0.001) (Figures 3f and g). This conﬁrms the involvement
of cathepsin-B and -L in simvastatin-induced cell death.
Mevalonate cascade inhibition promotes the unfolded
protein response (UPR). ER stress develops in response
to harsh environmental cues and the UPR is induced to
facilitate adaptation to the changing environment and
re-establish homeostasis and ER function. We measured
the impact of simvastatin exposure on expression and
activation of ER stress sensors and markers, including BIP
(GRP78), inositol-requiring enzyme alpha 1 (IREa1), activat-
ing transcription factor 6 (ATF6) and protein kinase PERK
(protein kinase-like endoplasmic reticulum kinase), which
mediate the activation of the UPR in mammalians cells.
20 As
shown in Figure 4a, mevalonate cascade inhibition leads to
increased expression of BIP (GRP78) and IREa1, cleavage
of ATF6 and phosphorylation of PERK. The activation of the
UPR ultimately leads to the attenuation of protein translation
(eIF2a phosphorylation), X box-binding protein 1 (XBP1)
splicing and increased expression of C/EBP homologous
protein (CHOP), a protein that links chronic ER stress to
apoptosis.
21 Figure 4a further demonstrates that each of
these UPR-triggered responses is induced in hATF upon
simvastatin exposure. Furthermore, nuclear accumulation of
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Cell Death and Diseasethe UPR-related transcription factors, ATF4, cleaved ATF6
and spliced XBP1 was evident (Figure 4b). In many cell types
the UPR is also associated with activation of ER-associated,
caspase-4
22,23 and its expression and cleavage is increased
during ER stress;
24 we conﬁrmed that this was the case
with mevalonate cascade inhibition in hATF (Figure 4c).
To conﬁrm that caspase activation was a component of ER-
linked cell death we tested the impact of speciﬁc inhibitors of
caspase-4 (Z-LEVD-FMK, 10mM) on simvastatin-induced
cell death with lowest possible effective concentration based
on our experience and that of others
23,25 and found that they
could partially prevent loss of cell viability (Po0.001)
(Figure 4d) in concert with suppressive effects on caspase-
3/7 activity (Figure 4e).
Exogenous mevalonate suppresses simvastatin-
induced, autophagy, UPR and apoptosis. We questioned
whether co-incubation of simvastatin-treated cells with
mevalonate could prevent the apoptotic, autophagic and/or
UPR responses. By immunoblotting we observed that
Figure 1 Mevalonate cascade inhibition induces cell death in primary myocardial atrial ﬁbroblast. (a) Cells were treated with simvastatin (5, 10, 15 or 20mM) and cell
viability was assessed 48 and 96h thereafter by MTT assay. Control cells for each time point were treated with the solvent control (DMSO). Results are expressed as
percentage of corresponding time point control and represent the mean±S.D. of nine independent experiments in three different of patient myocardial atria ﬁbroblast
(***Po0.001). (b and c) Effects of supplementation with 2.5 and 5mM mevalonate on cell viability (MTT Assay) (b) and cell morphology (c), to treatment with simvastatin
(10mM, 48 and 96h) on simvastatin-induced cell death. Cells were pretreated with indicated concentration of mevalonate (4h) and then co-treated with simvastatin (10mM,
48 and 96h). For each experiment control cells were treated with simvastatin and mevalonate solvent (DMSO and ethanol) alone. Results are expressed as mean±S.D. of
nine independent experiments using three different myocardial atrial ﬁbroblast primary cells (***Po0.001). (d) Effects of supplementation with cholesterol (0–50mM) on cell
viability (MTT Assay), with simvastatin (10mM, 48 and 96h). Cells were pretreated with indicated concentration of cholesterol (4h) and then co-treated with simvastatin
(10mM, 48 and 96h). For each experiment control cells were treated with simvastatin and cholesterol solvent (DMSO and ethanol) alone (control) or with both. Results are
expressed asmean±S.D.of nineindependent experimentsusingthreedifferentmyocardial atrialﬁbroblast primarycells(NS,nonsigniﬁcant). (e)Timecourseof simvastatin
(10mM) on the abundance of RhoA, RohC and Rac1/2/3 and in membrane and cytosolic fractions obtained from myocardial ﬁbroblast (western blot). Presence of
pan-Cadherin was used to normalize for loading of membrane fractions. Data are typical of two independent experiments using different primary cultures
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Cell Death and Diseaseexogenous mevalonate inhibited markers of the autophagy
response (LC3b-lipidation), UPR (eIF2a-phosphorylation,
IREa1, ATF4 expression, ATF6 cleavage) and apoptosis
(caspase-3 and -7 cleavage) (Figures 5a and b). These
ﬁndings are consistent with data in Figure 1b that indicate
exogenous mevalonate prevents simvastatin-induced loss of
hATF viability.
Mevalonate cascade inhibition affects B-cell lymphoma 2
(Bcl-2) protein expression and decreases mitochondrial
membrane potential. Bcl-2 family proteins regulate apoptosis
via modulation of mitochondrial outer membrane integrity: Bcl-
2 and Bcl-XL prevent the release of apoptogenic proteins from
mitochondria, whereas Bax, Bak, Bad, PUMA and NOXA
induce outer membrane permeabilization causing the release
of proapoptotic factors.
26 We examined differential expression
of Bcl-2 family proteins in simvastatin-treated hATF. Mevalo-
nate cascade inhibition decreased abundance of antiapoptotic
Bcl-2 and Mcl-1 while increasing proapoptotic Bax, NOXA,
PUMA, BNIP3 (30 and 60kDa) and BAD in whole-cell lysates
(Figure 6a). Simvastatin caused Bax accumulation in cytosolic
fractions, and in mitochondria-enriched fractions there was
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Figure3 Mevalonatecascadestimulatesautophagyinprimaryhumanmyocardialatrialﬁbroblast.(a)Myocardialatrialﬁbroblastcellswereeitherleftuntreated(topleft)or
they were treated with 10mM simvastatin (top right, and lower panels) for 72h. Cells were then imaged by TEM. Magniﬁcation: 3.4 10
3. Structures identiﬁed as
autophagosomes can be seen as double-membrane vacuoles in magniﬁed part of the ﬁgures. (b) Western blot analysis of cell lysates from myocardial atrial ﬁbroblast. Cells
were treated with 10mM simvastatin for the indicated time periods, and then immunoblotted using the indicated speciﬁc antibodies. GAPDH was used as loading control.
(c) Myocardial atrial ﬁbroblast treated with simvastatin (þSimva, 10mM, 72h) showed increased Lysotracker Red staining, a marker of lysosomal activation. (d) Myocardial
atrial ﬁbroblast cells treated with simvastatin showed an increase in LC3-b (green) punctuate indicating autophagosome formation. (e) Western blot analysis of cell lysates
from myocardial atrial ﬁbroblast cells. Cells were treated with 10mM simvastatin for the indicated time points and then immunoblotted using the indicated speciﬁc antibodies.
SimvastatininducedlatecathepsinLandearlycathepsin-Bactivation.(fandg)Myocardialatrialﬁbroblastwerepretreatedwithspeciﬁccathepsin-Binhibitor(CA-074,4h,f)or
cathepsin-B and -L inhibitor (ZFF-fmk, 4h, g) and then co-treated with simvastatin (10mM) for indicated time points. Cell viability was measured using MTT assay. Cathepsin
inhibitors signiﬁcantly inhibited simvastatin-induced cell death in myocardial atrial ﬁbroblast (***Po0.001)
Figure 2 Mevalonate cascade inhibition stimulates intrinsic caspase-dependent apoptosis in primary myocardial atrial ﬁbroblast. (a) Examples of typical scattergrams obtained
by LSCofmyocardial ﬁbroblastcells treatedwith vehiclecontrol or 10mMsimvastatinfor 48 and 96h. yaxis data represent total integrated ﬂuorescence of individual events (nuclei)
and x axis shows maximum pixel ﬂuorescence intensity within each event contour. Horizontal axis in each scattergram represents the threshold determined for reliable event
identiﬁcation, and the vertical line represents the outer boundary for normal cell pixel intensity (determined from control data). The position of cells with diploid or tetraploid nuclear
DNA, representing G0/G1 or G2 cell cycle phase, is indicated in each scattergram. Percentages shown in upper quadrants indicate the mean % of cells determined from three
separate experiments. Event frequency from color-coded ROI’s from scattergrams are used to populate the histogram in panel 2c (below). Color-coding: White region represents
healthy cells with integrated (2N or 4N) nuclear ﬂuorescence inthe G0/G1 and G2 phase of the cell cycle; Red region represent cells inwhich nuclear condenstation has occurred,
and likely represent cells in early apoptosis (shifted right on X-axis for maximum pixel nuclear ﬂurescence); and, Yellow region represents cells with reduced integrated nuclear
ﬂuorescence (DNA cleavage), and includes cells that exhibit more advanced apoptosis (increasing DNA cleavage and loss of DNS condensation), that correspond to a subG0/G1
population. (b) Galleries of images for individual cells representing events for ‘healthy’ hATF (from the white color-coded region in a) and simvastatin-treated (10mM, 96h) ‘early
apoptotic’cellsG0/G1cells(fromtheredcolor-codedregionin a).(c)Histogramsummarizing%apoptosisofcellsextractedfromLSCscattergramsofcontrolandsimvastatin-treated
hATF (10mM, 96h). Apoptotic cell counts included the sum of hATFs from both the red and yellow colored regions of scattergrams (e.g. a). Results represent three different
independent experiments in two different sets of primary atrial ﬁbroblast. (d) Immunoblot BID, cleaved caspase-3, -6, -9 and -7 in total cell lysates of primary myocardial ﬁbroblast.
Cellsweretreatedwithsimvastatin(10mM)forupto120h.Arrowsindicatepositionsandapproximatemolecularweightofpredictedandvisibleproteinsignals.ForalllanesGAPDH
was used as protein loading control. Blots are typical of three experiments completed using different patient cultures of atrial ﬁbroblast
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Cell Death and Diseaseaccumulation of proapoptotic Bax, PUMA, NOXA and BNIP3
with concomitant loss of antiapoptotic Bcl-2, Mcl-1 and Bcl-XL
(Figure 6b). In concert with accumulation of proapoptotic
proteins in mitochondria, mitochondrial membrane potential
(Dc) was also decreased (Figure 6c).
c-Jun N-terminal kinase/stress-activated protein kinase
(JNK/SAPK) signaling appears to promote decreased Bcl-2
expression and subsequent apoptosis induction in some cell
types, and chronic UPR reportedly triggers JNK/SAPK
activation.
20,27 Thus, we examined whether simvastatin-
induced loss of Bcl-2 is associated with and dependent on
JNK/SAPK activation. Indeed, mevalonate cascade inhibition
caused JNK/SAPK phosphorylation (Figure 6d), and the
speciﬁc JNK/SAPK inhibitor, SP600125 (150nM, 72h),
concomitantly inhibited simvastatin-induced cell death
(Po0.01) (Figure 6e) and loss of antiapoptotic Bcl-2
(Figure 6f). Taken together, these data indicate altered Bcl-2
family expression is linked to mevalonate cascade inhibition-
induced cell death, and this is, in part, associated with JNK/
SAPK activation that prevents loss of Bcl-2.
Autophagy negatively regulates mevalonate depletion-
induced apoptosis and UPR. We used two approaches to
assess whether autophagy inhibition may regulate mevalo-
nate cascade-dependent apoptosis and UPR: (1) chemical
inhibition of autophagy ﬂux by preventing autophagosome-
lysosome fusion with baﬁlomycin-A1; and, (2) assessing
responses in autophagy protein 5 (ATG5)-deﬁcient mouse
embryo ﬁbroblasts (ATG5 KO MEF). Baﬁlomycin-A1 aug-
mented simvastatin-induced LC3b II accumulation, indicating
that autophagy ﬂux was prevented (Figure 7a). Notably, this
was accompanied by an increase in caspase-7 and -9
activation and increased in BIP and IREa1, indicating
apoptosis and UPR responses were augmented by autop-
hagy inhibition. Consistent with these data, baﬁlomycin-A1
also signiﬁcantly (Po0.001) increased mevalonate cascade
inhibition-induced cell death in hATF (Figure 7b).
ATG5 conjugates with ATG12 and associates with isolated
membranes to form autophagosomes.
28 Though the extent to
which ATG5 KO MEF may undergo some form of adaption is
noteasilydiscerned,wedidobservethatmevalonatecascade
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Figure 4 Mevalonate cascade inhibition induces endoplasmic reticulum stress and activates UPR in primary human myocardial atrial ﬁbroblast. (a) Western blot analysis
of cell lysates from myocardial atrial ﬁbroblasts. Cells were treated with 10mM simvastatin before sample preparation at the indicated times. Immunoblotting was performed
using the indicated speciﬁc antibodies. Simvastatin increased the expression of IREa1, CHOP and ATF4 and enhanced ATF6 cleavage, XBP1 splicing, eif2a and PERK
phosphorylation.EqualproteinloadingwasconﬁrmedbydetectingGAPDHprotein.(b)Simvastatinincreasednuclearaccumulationofendoplasmicreticulum-relatedproteins.
Cellsweretreatedwithsimvastatin(10mM)forindicatedtimepointandcytosolicandnuclearfractionswereprepared.SimvastatinincreasedATF4,cleavedATF6andspliced
XBP1 nuclear content. HDAC1 was used to assess fraction purity and as an equal loading control. (c) Simvastatin activated endoplasmic reticulum-related caspase. Cells
were treated with simvastatin then cell lysates were probed for caspase-4 cleavage by immunoblot. Simvastatin induced caspase-4 activation. Equivalent loading was
conﬁrmed using GPADH. (d and e) Myocardial atrial ﬁbroblasts were pretreated with caspase-4 inhibitor (Z-LEVD-FMK, 10mM) for 4h and then co-treated with simvastatin
(10mM, 96h). Cell viability was measured using MTT assay. Caspase-4 inhibitor signiﬁcantly decreased simvastatin-induced cell death and caspase-3/-7 activation
(f) (***Po0.001)
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Cell Death and Diseaseinhibitionresultedinasigniﬁcantlygreaterdegreeofcelldeath
compared with wild-type MEF (Po0.001) (Figure 7c). This
was associated with greater caspase-7 activation and higher
BIP (GRP78) expression (Figure 7d). This data further reveal
that autophagy negatively regulates mevalonate cascade-
induced apoptosis and UPR.
Discussion
Disruption of the mevalonate cascade reportedly affect
apoptosis, autophagy and UPR/ER stress in cancerous and
noncancerous cells, but the simultaneous interactions
between the three responses are not described. The current
study demonstrates and deciphers interplay between these
cellular stress responses upon exposure to a clinically
relevant mevalonate cascade inhibitor, simvastatin, and does
so in primary cultured hATF. As such, in these cells we
provide ﬁrst time insight concerning apoptosis and ER stress
pathways, and the modulating impact of autophagy, which
ultimately was not sufﬁcient to prevent cell death. Figure 8
summarizes the coordinated interactions we uncovered, and
discuss hereafter. Our data are relevant as induction of
apoptosis in myoﬁbroblasts diminish their number in myocar-
dium and may be modulated by autophagy, thus regulating
thepotential forextracellular matrix deposition in the diseased
myocardium.
Our ﬁndings highlight a possible role for isoprenoid
intermediates of the mevalonate cascade in cell function
and survival. Simvastatin-induced cell death of hATF is not
mediated by reduced cholesterol synthesis per se, rather is
tied to limiting the availability of isoprenoid chains needed for
membrane anchoring of Ras superfamily GTPases. This is
consistent with other reports, including our own on human
lung mesenchymal cells.
12,29 In the present study,
we demonstrate that simvastatin limits the expression of
the antiapoptotic protein, Bcl-2, an effect associated with
JNK/SAPK activation (Figure 8). Moreover, mevalonate
cascade inhibition induces apoptosis, UPR/ER stress and
release of activated lysosomal cathepsins. These responses
are restricted by a simultaneous induction of autophagy ﬂux.
These insights are important, given the long-term usage of
statins in the general population, as we unveil cellular
responses that could be associated with clinical effects of
statins.
Consensus on the effect of statins on UPR and ER stress
has not been reached, in part because of the broad range of
intracellular effects caused by mevalonate cascade inhibition
in different cell types. Statins can inhibit ER stress,
30 but
reportedly can also activate UPR and ER stress,
11,31 whereas
other studies report no effect on UPR and ER stress.
32 These
inconsistencies suggest that mevalonate cascade-associated
regulation of UPR and ER stress may be conditional on the
cells studied and experimental conditions, for instance
metabolic changes that can develop upon cell transformation.
In hATF we found simvastatin increased spliced XBP1, a
response that has not yet been clearly linked to speciﬁc
functional responses in different cells.
33 Nonetheless, it may
be an early cell survival response or could activate other
signaling pathways during statin-induced ER stress. Further
investigation is needed to elucidate how statin-induced XBP1
splicing affects cell response and fate.
The UPR is thought to be adaptive, re-establishing home-
ostasis and normalizing ER function in a changing environ-
ment. UPR activation triggers transcriptional responses that
increase expression of genes encoding products that adjust
ER protein folding capacity and ER-assisted protein degrada-
tion. Without homeostatic balance, the cell dies,
34 thus
triggering the UPR that can result in cell adaptation, alarm
or apoptosis.
20 Our results show that mevalonate cascade
inhibition induces UPR: increased IREa1 and BiP/GRP78,
cleavage of ATF6, phosphorylation of PERK, XBP1 splicing
and nuclear accumulation of ATF4 and ATF6 (Figure 8). This
is accompanied by the accumulation of CHOP (also known as
growth-arrest and DNA damage inducible gene 153
(GADD153)), a protein initially linked with responses to DNA
damage.
35 The gene promoter for CHOP contains regulatory
elements for inducers of the UPR, including ATF4 and
ATF6.
36 CHOP regulates transcription of genes encoding
Bcl-2 family proteins
37 and can provoke caspase activation,
thus triggering cell demise. In the context of our studies, statin
exposure could trigger UPR and Bcl-2 protein-mediated
apoptosis via pathways involving CHOP.
We show that other pathways also contribute to altered
Bcl-2 expression in statin-treated hATF (Figure 8). Bcl-2
family proteins regulate cell death, carrying out their function
by controlling mitochondrial permeability. We found that
mevalonate cascade inhibition promoted accumulation and
mitochondrial association of proapoptotic Bcl-2 proteins
(Bax, Bad, PUMA, NOXA and BNIP3), whereas there was a
decrease in cytosolic abundance of antiapoptotic Bcl-2
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Figure 5 Mevalonate inhibits simvastatin-induced autophagy, endoplasmic
reticulum stress and apoptosis. Myocardial atrial ﬁbroblast were pretreated with
mevalonate(2.5mM,4h)andthenco-treatedwithsimvastatin(10mM)forindicated
time points. Immunoblots of cell lysates showed inhibition of (a) autophagy,
endoplasmic reticulum stress and (b) apoptosis markers
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Cell Death and Diseaseproteins (Bcl-2, Mcl-1 and Bcl-xL). The proapoptotic activity of
PUMA is initiated by interaction with Bcl-2 in mitochondria,
38
and we have reported that PUMA localizes to mitochondria,
reduces mitochondrial membrane potential, and induces
intrinsic apoptosis pathways in human airway smooth
muscle.
13 In our current study, decreased Bcl-2 in hATF
was mediated, at least in part, byJNK/SAPK phosphorylation,
and the JNK/SAPK inhibitor SP600125 was sufﬁcient to
prevent hATF death. These ﬁndings are consistent with work
showing that Bcl-2, Bcl-xL and Bcl-w inhibit apoptosis, and
that JNK/SAPK contributes to apoptosis through direct
phosphorylation of Bcl-2 or transcriptional downregulation of
Bcl-2 and c-IAP1.
39,40 Thus, it appears that statins modulate
upstream regulatory events that can converge to alter Bcl-2
expression and distribution, and trigger intrinsic apoptosis in
hAFTs.
Our ﬁndings reveal the existence of mevalonate
cascade-linked regulatory axes that modulate ER proteases.
Caspase-4isamemberofthegroupIfamilyofcaspases.
41Its
activation is associated with ER stress-induced cell
death.
42,43 We show that simvastatin activates caspase-4 in
hATF cells, and inhibition of caspase-4 suppresses caspase-
3/-7 activation and intrinsic apoptosis-driven cell death.
In simvastatin-treated hATF cells we found marked
cleavage and activation of cathepsin-B and -L, markers of
lysosomal activation that can contribute to cell death.
44,45
Once released from lysosomes, cathepsins can cleave
cellular substrates and act in concert with caspases to
disrupt the mitochondrial transmembrane potential. A role
for simvastatin-induced loss of lysosomal integrity and
cathepsin-B and -L activation in apoptosis appears to exist,
as we show they undergo cleavage, and cell death of hATF is
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Figure 6 Mevalonatecascadeinhibitionchangesthebalanceandlocalizationof antiandproapoptoticBcl-2familymemberandaffectsmitochondrialmembranepotential
in myocardial atrial ﬁbroblast. (a and b) Myocardial atrial ﬁbroblasts were treated with simvastatin (10mM) for indicated times and pro and antiapoptotic Bcl-2 family member
expression and localization (cytosolic/mitochondria-enriched fraction) were investigated using immunoblotting. Mevalonate cascade inhibition increased proapoptotic Bcl-2
family member expression and their mitochondrial localization while also decreasing antiapoptotic Bcl-2 family members and their mitochondrial localization. (c) Simvastatin
decreased mitochondrial membrane potential in treated myocardial atrial ﬁbroblast. Cells were treated with simvastatin (10mM, 72h) and mitochondrial membrane potential
were measured using JC-1 (***Po0.001) (see Materials and Methods section for details). (d–f) Mevalonate cascade inhibition decreased Bcl-2 expression via SAPK/JNK
activation in myocardial atrial ﬁbroblast. Cells were treated with simvastatin (10mM) for indicated time points. Simvastatin increased SAPK/JNK phosphorylation (d) and (e)
SAPK/JNK inhibitor (SB600123, 150nM) signiﬁcantly (**Po0.01) enhanced cell viability in the presence of simvastatin (10mM, 72h). Cells were pretreated with indicated
concentration of SB600123 for 4h and then co-treated with indicated concentration of simvastatin. Cell viability was measured using MTT assay. (f) SAPK/JNK inhibitor
(SB600123, 150nM) also inhibited the effect of simvastatin (10mM, 72h) on Bcl-2 expression
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Cell Death and Diseasesigniﬁcantly suppressed by their respective selective inhibi-
tors. In concert, simvastatin also induces autophagy, and
Baf-A1 promotes accumulation of lipidated LC3; thus, our
data indicate that autophagy ﬂux is not directly affected by
cathepsin release. This is consistent with ﬁndings in human
HONE 1 nasopharyngeal carcinoma cells in which autophagy
ﬂux was unaffected by lysosome damage.
46 Our ﬁndings
suggest the antiapoptotic and proapoptotic mechanisms of
autophagy and lysosomal damage are mutually exclusive,
though the hATF death response likely reﬂects the combined
impact of each pathway (Figure 8).
During ATGs and organelles are engulfed by double-
membrane vesicles to form autophagosomes that ultimately
fuse with lysosomes, leading to content degradation by
lysosomal enzymes.
47 Multiple studies show that apoptosis
and autophagy are linked, and there is evidence for
coordinated regulation of autophagy and ER stress in
determining cell survival or death.
48–52 Indeed, autophagy is
activated by a number of stressors including the UPR.
53,54
This is noteworthy because though our current work shows
thatstatin exposure promotesmultiple pathwaysthatcanlead
to cell death, we also observed a marked induction of
autophagy; a response that clearly tempers hATF demise.
In human lung mesenchymal cells suppression of the
mevalonate cascade underpins p53-regulated autophagy ﬂux
that attenuates intrinsic apoptosis.
12 The present study
with hATF shows that chemical inhibition of autophagy ﬂux
has broader effects, as it attenuates statin-induced ER stress/
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Figure 7 Mevalonate cascade-stimulated autophagy inhibition increases apoptosis and endoplasmic reticulum stress response and increases cell death (a) Myocardial
atrial ﬁbroblast were pretreated with baﬁlomycin-A1 (0.01mM, 4h) and then co-treatedwith simvastatin(10mM) for indicatedtime point. Inhibitionof autophagyﬂux increased
LC3b II accumulation, caspase-3, -7 and -9 cleavage and IREa1 and BIP (GRP78) expression. (b) Baﬁlomycin-A1 (5 and 10nM) pre and then cotreatment with simvastatin
(10mM)signiﬁcantlyincreasedsimvastatin-inducedlossofviabilityofmyocardialatrialﬁbroblast(***Po0.001).CellviabilitywasmeasuredusingMTTassay.(candd)Mouse
embryo ﬁbroblasts that express ATG5 and ATG5 knockout cells were treated with simvastatin (10mM). ATG5 knockout cells exhibited signiﬁcantly greater loss of cell viability
(measured by MTT assay) in response to simvastatin (***Po0.001) (96h) (d) and also increased caspase-7 cleavage and BIP expression. Equal loading was conﬁrmed
using b-actin
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NOXA
PUMA
Bax Mcl1
Bcl-2
simvastatin
XBP splicing
Cell Death
PERK
ATF4
IRE1
CHOP
Apoptosis Apoptosis
P-JNK
CATH-B
CATH-L
Caspase-7 & -9
UPR/ER stress
Autophagy
LC3-β
Lysosome
disruption
?
BIP/GRP78
Pro
Anti
Figure 8 Schematic pathway highlighting major events in mevalonate cascade
inhibition-induced cell death in hATF: HMG-CoA inhibition with simvastatin
concomitantly induces apoptosis, autophagy and UPR/ER stress in hATF.
Apoptosis initiation is driven by disruption of balance between pro and antiapoptotic
Bcl-2 proteins. HMG-CoA inhibition also promotes UPR/ER stress as indicated by
an increase in BIP/GRP78, and the activation of ATF4 and PERK, which in turn
activate CHOP to support apoptosis. IREa1 is also activated, which leads to JNK
phosphorylation (P-JNK) that contributes to loss of Bcl-2, further promoting
apoptosis. IREa1 activation also triggers XBP1 splicing (but direct effects on
apoptosis are not clear, as denoted by ‘?’). Inhibiting HMG-CoA also leads to
leak of cathepsin (CATH)-B and CATH-L from lysosomes to augment apoptosis.
HMG-CoAinhibitionalsoinducesautophagyﬂux(LC3-IIaccumulation),whichhasa
suppressive role, negatively regulating apoptosis (cell viability, caspase-7 and -9)
and UPR (BIP/GRP78, IREa1), albeit the autophagy response is not sufﬁcient to
ultimately prevent cell death
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Cell Death and DiseaseUPR (BIP/GRP78 and IREa1 expression) and activation of
intrinsic apoptosis (capase-9, -7 and -3). Moreover, in MEF
lacking ATG5, induction of markers of ER stress, UPR and
apoptosis by mevalonate cascade inhibition were similarly
blunted. Prevention of autophagosome degradation upon
lysosome fusion with the vacuole H
þ-ATPase inhibitor, Baf-
A1 or preventing more proximal autophagosome formation in
ATG5 KO MEF was equally effective in enhancing simvasta-
tin-induced cell death. In mammalian cells, autophagosomes
form in the cytosol and then fuse with lysosomes under the
control of distinct mechanisms.
55 Thus, simvastatin-induced
autophagy in hATF involves enhanced autophagosome
synthesis and ﬂux and their regulation modulates cell stress
responses that can lead to cell death.
Ourstudy focusesontheimpactofsimultaneous initiationof
autophagy, apoptosis and ER stress following inhibition of
HMG-CoAreductaseusingstatins,providingunderstandingof
theirinterplayinhomeostasis,survivalandprogrammed death
of primary hATFs. Although apoptosis is a tightly regulated
cellular suicide program, autophagy can promote both cell
survival and cell death. This study demonstrates that a
clinically relevant inhibitor of the mevalonate cascade can
induce hATF demise, a response that manifests from complex
mechanisms involving co-regulation of ER stress, UPR and
apoptosis. Coincident induction of autophagy determines the
extent of the stress response and permissiveness for cell
death, but in the cell system we employed this was not
sufﬁcient to prevent eventual cell death.
Materials and Methods
Reagents. Cell culture plasticware was obtained from Corning Inc. (Tewksbury,
MA, USA). Cell culture media, propidium iodide, simvastatin, CA-074-ME,
ZFF-FMK, mevalonate, cholesterol, MTT, rabbit anti-human/mouse/rat LC3b, and
mouse anti-human/mouse BNIP3 were obtained from Sigma (Sigma-Aldrich,
Oakville, CA, USA). Z-LEVD-FMK was purchased from Calbiochem :EMD Millipore
(Darmstadt, Germany). Rabbit anti-human cleaved caspase-7,-3 JNK/SAPK,
phospho JNK/SAPK, rabbit anti-Bak, Bax, PUMA, Bcl-2, Bid, Mcl-1, Bcl-XL Rac1/2/
3, p21, RhoA, RhoC, GRP78 (BIP), IREa1, eif2a, phospho-eif2a, Atg5, Beclin-1
and Pan-cadherin were purchased from Cell Signaling Technology (Beverly, MA,
USA). Rabbit anti-PERK, phospho-PERK, mouse anti-glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) and SP600125 were obtained from Santa Cruz
Biotechnology Inc. (Santa Cruz, CA, USA). Rabbit anti-NOXA, anti-ATF6, anti-
ATF4, anti-XBP1, anti-caspase-4, Cathepsin-B and mouse anti-Cathepsin L were
obtained from Abcam (Cambridge, MA, USA). 5,50,6,60-tetrachloro-1,10,3,30-
tetraethylbenzimidazolylcarbocyanine iodide (JC-1), and Lysotracker Red, were
obtained from Invitrogen Molecular Probes (Burlington, ON, Canada). Casapase-
Glo-3/7 assay was purchased from Promega (Madison, WI, USA).
Primary human atrial ﬁbroblast (hATF) cell culture preparation.
Approval was obtained from the Bannatyne Campus Research Ethics Board of the
University of Manitoba for the collection of atrial tissue from patients undergoing a
cardiac surgical procedure. Written informed consent was obtained from each
patient before tissue collection. Fragments of atrial tissue were subjected to
collagenase digestion to isolate cardiac myoﬁbroblasts. Minced atrial tissue was
treated with 2mg/ml collagenase II (Worthington Biochemical Corp., Lakewood,
NJ, USA) in SMEM media (GIBCO/Life Technologies, Burlington, ON, Canada)
and incubated for 3h at 371C. Collagenase was neutralized by the addition of an
equal volume of medium containing 20% fetal bovine serum (FBS) and liberated
cells were collected by centrifugation at 2000r.p.m. for 7min. Cells were
resuspended in fresh complete medium containing 20% FBS, seeded onto plastic
culture dishes and incubated at 371Ci n5 %C O 2 and 95% humidity. The digestion
was repeated with the remaining tissue pieces. Non-adherent cells (myocytes)
were removed the next day and fresh medium was added to the adherent cells
and replaced every 3 or 4 days.
MTT assay. Cytotoxicity of simvastatin towards the hATF cells was determined
by MTT assays as previously described.
12 In experiments investigating the effects
of mevalonate (0–2.5mM), cholesterol (0–50mM), CA-074-ME and ZFF-FMK
(0–50mM), Z-LEVD-FMK (0–25mM) and SP600125 (10mM), hATF cells were
pretreated with the indicated concentration of the inhibitors or chemical (4h) and
then co-treated with indicated concentrations of simvastatin for experimental time
points. For each experiment time-matched vehicle controls were performed.
Luminescence caspase activity assays. Luminometric assays
Caspase-Glo-3/7 (Promega, Nepean, ON, Canada) was used to measure the
proteolytic activity of caspase-3/7 (DEVD-ase). The assays were performed
according to manufactures instructions with some modiﬁcation as detailed in our
previous work.
13
Quantitative analysis of nuclear ﬂuorescence using laser
scanning cytometry. Human atrial ﬁbroblast cells were grown to 80%
conﬂuence in Dulbeco’s Modiﬁed Eagle Medium (DMEM) supplemented with 10%
FBS on glass coverslips. At conﬂuence, the medium was replaced with DMEM
containing reduced serum (0.5% FBS) for 48h after which cells were incubated in
serum reduced medium with or without simvastatin (10mM). Fluorescent labeling
of live cell nuclei was carried out by incubation in Hank’s balanced salt solution
containing 5mg/ml Hoechst 33342 dye (15min, 371C). Quantitation and analysis
of nuclear DNA ﬂuorescence was carried out using a laser scanning cytometer
(Compucyte Corp., Westwood, MA, USA) as described before.
13
Analysis of cellular morphology. We assessed cell viability based
on gross cellular appearance (chromatin condensation and cell shrinkage) and the
effect of mevalonate on simvastatin (10mM) cytotoxicity at indicated time points on
hATF cells grown on 12-well plates by phase contrast microscopy (Olympus CK40;
Olympus Canada, Mississauga, ON, Canada) using a DP10 CCD digital camera to
capture images.
Membrane anchoring of Rho GTPases. For determination of mem-
brane anchoring of prenylated Rho and Rac GTPases, hATF cells were cultured in
DMEM/0.5% FBS in the presence or absence of simvastatin (10mM). After washing
cells were scraped in ice-cold buffer (10mM Tris-HCl, pH 7.5, 0.1mM EDTA, 0.1mM
EGTA, 1mM dithiothreitol and protease inhibitor cocktail), sonicated on ice 3  for
5s, and then the homogenate was separated into cytoplasmic and membrane
fractions by ultracentrifugation (100000 g for 35min). The membrane fractions
were solublized in dissociation buffer (50mM Tris-HCl, pH 7.5, 0.15M NaCl, 1mM
dithiothreitol, 1% SDS, 1mM EDTA, 1mM EGTA, protease inhibitor cocktail) and
subsequently size fractioned by SDS-PAGE for immunoblot analysis using anti-Rac1/
2/3 and anti-RhoA, and RhoC primary antibodies (Cell Signaling Technology).
Mitochondrial membrane potential assay. This assay was performed
using a mitochondria-speciﬁc cationic dye (JC-1), which undergoes potential-
dependent accumulation in mitochondria. hATF cells were seeded in black clear-
bottom 96-well plates. Following treatment with 10mM simvastatin for different
time intervals as indicated, mitochondrial membrane potential was measured as
previously described.
13
Immunoblotting. Blotting was used to detect cleaved caspase-3, -9, -7,
Bcl-2, Bid, PUMA, NOXA, Bax, ATF6, caspase-4, ATF4, IREa1, eif2a, phospho-
eif2a, PERK, phospho-PERK, Atg5-12, LC3b, beclin-1, Cathepsin-B, Cathepsin L,
Mn-SOD2, Pan-Cadherin and GAPDH. Brieﬂy, cells were washed and protein
extracts were prepared in lysis buffer (20mM Tris-HCl (pH 7.5), 0.5% Nonidet
P-40, 0.5mM PMSF, 100mM b-glycerol 3-phosphate and 0.5% protease inhibitor
cocktail). After centrifugation (13000 g, 10min), supernatant protein content
was determined by Lowry protein assay, then proteins were size fractionated by
SDS-PAGE and transferred onto nylon membranes under reducing conditions.
After blocking membranes with non-fat-dried milk and Tween 20, blots were
incubated overnight with the primary antibodies at 41C. HRP-conjugated
secondary antibody incubation was for 1h at RT, then blots were developed
with enhanced chemiluminescence regents (Amersham-Pharmacia Biotech/GE
Healthcare Life Sciences, Baie d’Urfe PQ, Canada).
Immunocytochemistry, confocal imaging and electron
microscopy. For immunocytochemistry, hATF cells were grown overnight on
coverslips and then treated with simvastatin (10mM) or vehicle for 72h.
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gies, Burlington, ON, Canada) (100nM, 10min) before ﬁxation (4% paraformal-
dehyde/120mM sucrose) and permeabilization (3% Triton X-100). Cells were then
incubated with rabbit anti-LC3b IgG (1:200) with corresponding ﬂuorochrome-
conjugated secondary antibodies. The ﬂuorescent images were then observed and
analyzed using an Olympus FluoView multi-laser confocal microscope. For
transmission electron microscopy (TEM), cells were ﬁxed (2.5% glutaraldehyde in
PBS (pH 7.4) for 1h at 41C) and post-ﬁxed (1% osmium tetroxide) before
embedding in Epon. TEM was performed with a Philips CM10, at 80kV, on ultra-
thin sections (100nm on 200-mesh grids) stained with uranyl acetate and
counterstained with lead citrate.
Subcellular fractionation. Following induction of cell death using
simvastatin (10mM), cytosolic, mitochondrial and nuclear fractions were
generated using a digitonin-based subcellular fractionation technique, essentially
as described previously.
13 Brieﬂy, 10
7 cells were harvested by centrifugation at
800 g, washed in PBS pH 7.2 and re-pelleted. Cells were digitonin-
permeabilized for 5min on ice at a density of 3 10
7/ml in cytosolic extraction
buffer (250mM sucrose, 70mM KCl, 137mM NaCl, 4.3mM Na2HPO4, 1.4mM
KH2PO4 pH 7.2, 100mM PMSF, 10mg/ml leupeptin, 2mg/ml aprotinin, containing
200mg/ml digitonin). Plasma membrane permeabilization of cells was conﬁrmed
by staining in a 0.2% trypan blue solution. Cells were then centrifuged at 1000 g
for 5min at 41C. The supernatants (cytosolic and mitochondrial fractions) were
saved and the pellets solubilized in the same volume of nuclear lysis buffer,
followed by pelletting at 12500 g for 10min at 41C. The mitochondria were
separated from the cytosolic fraction by pelleting at 13000 g. The pellets were
solubilized in equal amount of mitochondrial lysis buffer (50mM Tris pH 7.4,
150mM NaCl, 2mM EDTA, 2mM EGTA, 0.2 % Triton X-100, 0.3% NP-40,
100mM PMSF, 10mg/ml leupeptin, 2mg/ml aprotinin). For the detection of
proteins, equal amounts of fractionated protein were supplemented with 5  SDS-
PAGE loading buffer, subjected to standard 12% SDS-PAGE and transferred to
nitrocellulose membranes.
Statistical analysis. The results were expressed as means±S.D. and
statistical differences were evaluated by one-way or two-way ANOVA followed by
Tukey’s or Bonferroni’s post hoc test, using Graph Pad Prism 5.0 (Graph Pad
Software Inc., La Jolla, CA, USA). Po0.05 was considered signiﬁcant. In all
experiments data were collected in triplicate from at least three cell lines unless
otherwise indicated.
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